Treasure Island: The price for debt-to-equity swap by controlling shareholders will be reduced from 13.35 yuan per share to 12.35 yuan.

Recently, Heilongjiang Treasure Island Pharmaceutical Co., Ltd. received a notification from its controlling shareholder, Heilongjiang Chuangda Group Co., Ltd., that the conversion price of the first tranche of convertible bonds "23 Chuang01EB" due in 2023 will be adjusted. The bond was issued on April 11, 2023, with a size of 910 million yuan and a maturity of 3 years. In order to protect the interests of holders, Chuangda Group has decided to lower the conversion price. The decision was approved by the board of directors on August 11, and on August 20, bondholders agreed to lower the conversion price from 13.35 yuan/share to 12.35 yuan/share, effective as of August 27. After the adjustment, the pledged special account stocks still meet the conversion requirements.